StockData

Femasys Inc (FEMY) stock

FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3037% below fair value
$1.12−0.16 (-12.50%)

Close on Nov 17, 2026Market cap $9.38MP/E –Yield –

Femasys operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Femasys's operating cash flow for the twelve months ending Jun 30, 2026 was -$17.65M. For fiscal 2025 it was -$18.69M. The highest annual figure on record is -$4.93M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$18.69M–
FY2024Dec 31, 2024-$19.44M–
FY2023Dec 31, 2023-$11.28M–
FY2022Dec 31, 2022-$10.73M–
FY2021Dec 31, 2021-$7.93M–
FY2020Dec 31, 2020-$4.93M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.94M–
Q1 FY2026Mar 31, 2026-$4.14M–
Q4 FY2025Dec 31, 2025-$4.19M–
Q3 FY2025Sep 30, 2025-$5.39M–
Q2 FY2025Jun 30, 2025-$4.35M–
Q1 FY2025Mar 31, 2025-$4.77M–
Q4 FY2024Dec 31, 2024-$5.07M–
Q3 FY2024Sep 30, 2024-$5.47M–
Q2 FY2024Jun 30, 2024-$4.33M–
Q1 FY2024Mar 31, 2024-$4.57M–
Q4 FY2023Dec 31, 2023-$3.04M–
Q3 FY2023Sep 30, 2023-$2.86M–
Q2 FY2023Jun 30, 2023-$2.74M–
Q1 FY2023Mar 31, 2023-$2.65M–
Q4 FY2022Dec 31, 2022-$2.87M–
Q3 FY2022Sep 30, 2022-$2.73M–
Q2 FY2022Jun 30, 2022-$2.38M–
Q1 FY2022Mar 31, 2022-$2.75M–
Q4 FY2021Dec 31, 2021-$2.25M–
Q3 FY2021Sep 30, 2021-$1.80M–
Q2 FY2021Jun 30, 2021-$2.72M–
Q1 FY2021Mar 31, 2021-$1.16M–
Q4 FY2020Dec 31, 2020-$1.27M–
Q3 FY2020Sep 30, 2020-$859.02K–

More Femasys figures

See a number that looks wrong?